Cargando…

Onasemnogene abeparvovec for spinal muscular atrophy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427620/
https://www.ncbi.nlm.nih.gov/pubmed/36110172
http://dx.doi.org/10.18773/austprescr.2022.044
_version_ 1784778946728951808
collection PubMed
description
format Online
Article
Text
id pubmed-9427620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-94276202022-09-14 Onasemnogene abeparvovec for spinal muscular atrophy Aust Prescr New Drugs NPS MedicineWise 2022-07-07 2022-08 /pmc/articles/PMC9427620/ /pubmed/36110172 http://dx.doi.org/10.18773/austprescr.2022.044 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Onasemnogene abeparvovec for spinal muscular atrophy
title Onasemnogene abeparvovec for spinal muscular atrophy
title_full Onasemnogene abeparvovec for spinal muscular atrophy
title_fullStr Onasemnogene abeparvovec for spinal muscular atrophy
title_full_unstemmed Onasemnogene abeparvovec for spinal muscular atrophy
title_short Onasemnogene abeparvovec for spinal muscular atrophy
title_sort onasemnogene abeparvovec for spinal muscular atrophy
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427620/
https://www.ncbi.nlm.nih.gov/pubmed/36110172
http://dx.doi.org/10.18773/austprescr.2022.044